Copyright 1999 American Medical Association. All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.1999
To the Editor: In their exhaustive review of
the literature and their meta-analysis of aspirin and risk of hemorrhagic
stroke, Dr He and colleagues1 state that
"absolute risk measures the magnitude of aspirin use on risk of hemorrhagic
stroke." This is not technically correct. It would be more accurate to state
that absolute risk measures the risk of hemorrhagic stroke with aspirin or
placebo. Absolute risk increase measures the risk of hemorrhagic bleeding
attributable to aspirin.
Desbiens NA, Schmitt CM, Panda ML. Aspirin and Risk of Hemorrhagic Stroke. JAMA. 1999;282(8):731–733. doi:10-1001/pubs.JAMA-ISSN-0098-7484-282-8-jbk0825
Customize your JAMA Network experience by selecting one or more topics from the list below.